Western Wealth Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Western Wealth Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,330	Closed	-$67K	–	814
2022 Q3	$67K	Hold	17,330	–	–	﹤0.01%	790
2022 Q2	$98K	Hold	17,330	–	–	0.01%	764
2022 Q1	$254K	Buy	+17,330	New	+$232K	0.01%	732

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Western Wealth Management's DMTK Position: Q4 2022 in Review

Western Wealth Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 17,330 shares — an estimated $67K sold.

Western Wealth Management first reported a position in DMTK in Q1 2022 and held it in 3 quarters. The position peaked at $254K in Q1 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Western Wealth Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Western Wealth Management sold 17,330 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $67K.
Western Wealth Management first reported a position in DermTech, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Western Wealth Management's DermTech, Inc. Common Stock position peaked at $254K in Q1 2022.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Western Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.